Emergent BioSolutions Inc. (NYSE: EBS) today announced the exercise of contract option and modification valued at approximately $20 million to supply BioThrax® (Anthrax Vaccine Adsorbed) to the U.S.
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced that the National Medical Products Administration (NMPA) of China approved GARDASIL ® [Human Papillomavirus ...
SHELTON, CT / ACCESSWIRE / / Dr. Anil Diwan, President of NanoViricides, Inc. (NYSE American: NNVC ) (the "Company"), comments on the many viruses that could cause ...